These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 4020537)
41. Effect of 2,5-dimethoxy-4-methylamphetamine on heart and smooth muscle contraction. Huang JT; Ho BT J Pharm Pharmacol; 1974 Jan; 26(1):69-70. PubMed ID: 4150941 [No Abstract] [Full Text] [Related]
42. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response. Harvey JA; Gormezano I; Cool VA J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729 [No Abstract] [Full Text] [Related]
43. [Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy]. Furnari C; Ottaviano V; Rosati F Ann Ist Super Sanita; 2001; 37(2):297-300. PubMed ID: 11758288 [TBL] [Abstract][Full Text] [Related]
44. Assessment of tolerance to the hallucinogenic effects of DOM. Angrist B; Rotrosen J; Gershon S Psychopharmacologia; 1974 Apr; 36(3):203-7. PubMed ID: 4844244 [No Abstract] [Full Text] [Related]
45. Triphasic dose-lethality relationships for amphetamine and certain ring-substituted amphetamines in isolated or aggregated mice. Davis WM; Waters IW; Hatoum HT; Buelke JL; Braude MC Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):575-82. PubMed ID: 578333 [No Abstract] [Full Text] [Related]
46. A crystallographic and theoretical study of the conformation of DOET and its significance for the hallucinogenic amphetamines. Horn AS; Post ML; Kennard O; Di Sanserverino R J Pharm Pharmacol; 1975 Jan; 27(1):13-7. PubMed ID: 235609 [TBL] [Abstract][Full Text] [Related]